References
- Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–3008.
- Bezzeccheri AA, Vermeersch P, Verheye S, et al. Trends and outcomes in transcatheter aortic valve implantation in Belgium: a 13-year single center experience. Acta Cardiol. In press.
- Linder M, Seiffert M. Periprocedural strategies for stroke prevention in patients undergoing transcatheter aortic valve implantation. Front Cardiovasc Med. 2022;9:892956.
- Kapadia SR, Krishnaswamy A. Cerebral embolic protection in transcatheter aortic valve replacement: connecting intuition and proof. JACC Cardiovasc Interv. 2021;14(2):169–171.
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–1705.
- Sathananthan J, Lauck S, Polderman J, et al. Ten year follow‐up of high‐risk patients treated during the early experience with transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2021;97(3):E431–E437.
- Lancellotti P, Martinez C, Radermecker M. The long quest for the holy grail in transcatheter aortic bioprosthesis: durability and long-term performance. J Am Coll Cardiol. 2019;73(5):554–558.
- Rück A, Saleh N, Glaser N. Outcomes following permanent pacemaker implantation after transcatheter aortic valve replacement: SWEDEHEART observational study. JACC Cardiovasc Interv. 2021;14(19):2173–2181.
- Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014;129(11):1233–1243.
- Wu S, Sharma PS, Huang W. Novel left ventricular cardiac synchronization: left ventricular septal pacing or left bundle branch pacing? Europace. 2020;22(2):ii10–ii18.
- Gupta R, Mahajan S, Behnoush AH, et al. Short-and long-term clinical outcomes following permanent pacemaker insertion post-TAVR: a systematic review and Meta-analysis. JACC Cardiovasc Interv. 2022;15(16):1690–1692.
- Seo J, Kim DY, Cho I, et al. Prevalence, predictors, and prognosis of tricuspid regurgitation following permanent pacemaker implantation. PLoS One. 2020;15(6):e0235230.
- Van Belle E, Vincent F, Labreuche J, et al. Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a propensity-matched comparison from the France-TAVI registry. Circulation. 2020;141(4):243–259.
- Deharo P, Bisson A, Herbert J, et al. Impact of sapien 3 balloon-expandable versus evolut R self-expandable transcatheter aortic valve implantation in patients with aortic stenosis: data from a nationwide analysis. Circulation. 2020;141(4):260–268.
- Thiele H, Kurz T, Feistritzer HJ, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020;41(20):1890–1899.
- Abdel-Wahab M, Thiele H. Transcatheter heart valve design and mortality. Truth or Dare? Circulation. 2020;14(4):269–272.